PARIS (AP) — Over a year ago, France was shaken by a shocking case in which dozens of men were accused of raping a drugged woman, Gisèle Pelicot, with the help of her husband. The country is still grappling with the prevalence of drug-facilitated sexual assault as a former senator goes on trial, accused of slipping MDMA into a fellow lawmaker’s drink in order to abuse her.

Joël Guerriau, 68, is accused of putting the drug MDMA, known as ecstasy, in a glass of champagne he served to lawmaker Sandrine Josso in November 2023. He has admitted serving her a drink spiked with MDMA but says it was an accident.

Recommended for you

Copyright 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

Recommended for you

(0) comments

Welcome to the discussion.

Keep the discussion civilized. Absolutely NO personal attacks or insults directed toward writers, nor others who make comments.
Keep it clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't threaten. Threats of harming another person will not be tolerated.
Be truthful. Don't knowingly lie about anyone or anything.
Be proactive. Use the 'Report' link on each comment to let us know of abusive posts.
PLEASE TURN OFF YOUR CAPS LOCK.
Anyone violating these rules will be issued a warning. After the warning, comment privileges can be revoked.

Thank you for visiting the Daily Journal.

Please purchase a Premium Subscription to continue reading. To continue, please log in, or sign up for a new account.

We offer one free story view per month. If you register for an account, you will get two additional story views. After those three total views, we ask that you support us with a subscription.

A subscription to our digital content is so much more than just access to our valuable content. It means you’re helping to support a local community institution that has, from its very start, supported the betterment of our society. Thank you very much!

Want to join the discussion?

Only subscribers can view and post comments on articles.

Already a subscriber? Login Here